A genetic variant in the interleukin 28B gene as a major predictor for sustained virologic response in chronic hepatitis C virus infection.
暂无分享,去创建一个
M. Uribe | L. Amezcua-Guerra | A. Domínguez-López | M. Dehesa-Violante | F. Vargas‐Vorácková | L. Toapanta-Yanchapaxi | J. F. Sánchez-Ávila | I. García-Juárez | M. Sixtos-Alonso | R. Sandoval-Salas | I. García‐Juárez | R. Avalos-Martinez | A. Chávez-Ayala | J. Sánchez-Ávila
[1] P. Tangkijvanich,et al. Prevalence of Thymine—Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection , 2015, PloS one.
[2] T. Berg,et al. Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C , 2014, PloS one.
[3] L. Prokunina-Olsson,et al. Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus. , 2014, The Journal of infectious diseases.
[4] S. Khakoo,et al. Genetic Variation in the Interleukin-28B Gene Is Associated with Spontaneous Clearance and Progression of Hepatitis C Virus in Moroccan Patients , 2013, PloS one.
[5] Barbara Rehermann,et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus , 2013, Nature Genetics.
[6] A. Burguete-García,et al. IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population. , 2012, Annals of hepatology.
[7] S. El-Kafrawy,et al. Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort. , 2011, The Journal of infectious diseases.
[8] J. Pinho,et al. IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[9] M. Silva,et al. Genetic variation in interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin. , 2011, Annals of hepatology.
[10] Katherine D Gonzalez,et al. IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients. , 2011, World journal of gastroenterology.
[11] F. Negro,et al. Trends and projections of hepatitis C virus epidemiology in Latin America , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[12] S. Román,et al. Epidemiología de las hepatitis virales en México , 2011 .
[13] C. Thio,et al. IL28B and the control of hepatitis C virus infection. , 2010, Gastroenterology.
[14] M. Romero-Gómez,et al. Interleukin‐28B genetic variants and hepatitis virus infection by different viral genotypes , 2010, Hepatology.
[15] X. Lao,et al. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. , 2010, Gastroenterology.
[16] David B. Goldstein,et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.
[17] Jacques Fellay,et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.
[18] D. Kershenobich-Stalnikowitz,et al. Prevalence of hepatitis C virus genotypes in Mexican patients. , 2007, Revista de gastroenterologia de Mexico.
[19] J. Pawlotsky,et al. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. , 2007, World journal of gastroenterology.
[20] Asociación Mexicana de Hepatología. National Consensus of Hepatitis C. June 28-29, 2002. , 2002, Annals of hepatology.
[21] T. Poynard,et al. Meta‐analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration , 1996, Hepatology.
[22] R. Vázquez-Frias,et al. Mexican consensus on the diagnosis and management of hepatitis C infection. , 2015, Annals of hepatology.
[23] A ALBORNOZ PLATA,et al. [Epidemiology of viral hepatitis]. , 1951, Pediatria de las Americas.